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Background
Human topoisomerase II is present in two forms
170kDa a and 180 kDa b isoform. Early reports have
indicated that the topoII poisons and antisense RNA
can block viral replication. The objective of present
study is to evaluate specific requirement of topoII iso-
merases in promoting HIV replication and to character-
ize the HIV-1 replication intermediates to study
molecular action of the topoII a or/and b isoforms.
Methods
In topoII a or/and b were down regulated by using
siRNA mediated gene silencing in SupT1 cells and
infected with HIV-1 (93IN101) at mentioned time
points DNA and RNA were isolated and analyzed by
PCR. Co-localization studies were done by using fluores-
cent antibodies specific to RT, topoII a and topoII b
and images were taken in confocal microscopy.
Results
The results indicated that HIV-1 replication was aborted
in topoII a or/and b down regulated SupT1 cells. Analy-
sis of the intermediates formed during the HIV-1 repli-
cation cycle in topoII a-, topoII b-a n dt o p o I Ia- b-
SupT1 cells do not support viral gene expression, inte-
gration, PICs formation and cDNA synthesis. Moreover,
results revealed the topoII a and b co-localization with
HIV-1 reverse transcriptase. Taken together, results dis-
play the requirement of topoisomerase II isoforms in
the event of HIV-1 reverse transcription.
Conclusion
Topoisomerase II isoforms are involved in the HIV-1 life-
cycle in the early event of HIV-1 reverse transcription,
influencing the phenomenon through an unknown
mechanism.
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